Skip to main content
TipRanks
Go Ultimate75% OFF

MediXall Group (MDXL) Stock Statistics & Valuation Metrics

8 Followers

Total Valuation

MediXall Group has a market cap or net worth of $753.71K. The enterprise value is $4.97T.

Market Cap
$753.71K
Enterprise Value
$4.97T

Share Statistics

MediXall Group has 228,396,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
228,396,800
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

MediXall Group’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 145.40%.

Return on Equity (ROE)
0.70
Return on Assets (ROA)
-22.69
Return on Invested Capital (ROIC)
145.40%
Return on Capital Employed (ROCE)
0.60
Revenue Per Employee
44.20K
Profits Per Employee
-651.92K
Employee Count
7
Asset Turnover
1.54
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of MediXall Group is -0.09. MediXall Group’s PEG ratio is 0.00.

PE Ratio
-0.09
PS Ratio
2.19
PB Ratio
-0.06
Price to FCF
-0.55
Price to Operating Cash Flow
-0.34
PEG Ratio
0.00

Income Statement

In the last 12 months, MediXall Group had revenue of 309.42K and earned -4.56M in profits. Earnings per share was -0.04.

Revenue
309.42K
Gross Profit
72.91K
Operating Income
-3.92M
Pretax Income
-4.56M
Net Income
-4.56M
EBITDA
-3.88M
Earnings Per Share (EPS)
-0.04

Cash Flow

In the last 12 months, operating cash flow was -1.20M and capital expenditures 0, giving a free cash flow of -1.20M billion.

Operating Cash Flow
-1.20M
Free Cash Flow
-1.20M
Free Cash Flow per Share
-0.01

Dividends & Yields

MediXall Group pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-181.30%
Earnings Yield
-1087.43%

Stock Price Statistics

Beta
19.07
52-Week Price Change
0.00%
50-Day Moving Average
0.38
200-Day Moving Average
0.38
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Financial Position

MediXall Group as a current ratio of 0.00, with Debt / Equity ratio of -58.71%

Current Ratio
0.00
Quick Ratio
0.00
Debt to Market Cap
75.30
Net Debt to EBITDA
-0.98
Interest Coverage Ratio
-6.05

Taxes

In the past 12 months, MediXall Group has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

MediXall Group EV to EBITDA ratio is -1.16, with an EV/FCF ratio of -3.66.

EV to Sales
14.54
EV to EBITDA
-1.16
EV to Free Cash Flow
-3.66
EV to Operating Cash Flow
-3.66

Balance Sheet

MediXall Group has $31.92K in cash and marketable securities with $430.43K in debt, giving a net cash position of -$398.51K billion.

Cash & Marketable Securities
$31.92K
Total Debt
$430.43K
Net Cash
-$398.51K
Net Cash Per Share
$0.00
Tangible Book Value Per Share
-$0.02

Margins

Gross margin is 23.56%, with operating margin of -1265.64%, and net profit margin of -1474.82%.

Gross Margin
23.56%
Operating Margin
-1265.64%
Pretax Margin
-1474.82%
Net Profit Margin
-1474.82%
EBITDA Margin
-1254.56%
EBIT Margin
-1265.64%

Analyst Forecast

The average price target for MediXall Group is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―